Erlotinib: As Maintenance Monotherapy in Non-Small-Cell Lung Cancer

Author： Muir Victoria J.   Dhillon Sohita  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.3, 2011-06, pp. : 139-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synchronous neuroendocrine tumor and non‐small‐cell lung cancer in neurofibromatosis type 1

By  

Clinical Case Reports, Vol. 3, Iss. 12, 2015-12 ,pp. : 990-996

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic role of liver X receptor‐alpha in resected stage II and III non‐small‐cell lung cancer

By  

THE CLINICAL RESPIRATORY JOURNAL, Vol. 12, Iss. 1, 2018-01 ,pp. : 241-246

John Wiley & Sons Inc

Access to resources Recommend Favorite

Radiochemotherapy for Non Small Cell Lung Cancer

By  

Current Drug Therapy, Vol. 5, Iss. 3, 2010-08 ,pp. : 180-191

Bentham Science Publishers

Access to resources Recommend Favorite

Spotlight on Bevacizumab in Advanced Colorectal Cancer, Breast Cancer, and Non-Small Cell Lung Cancer

By Lyseng-Williamson Katherine A.   Robinson Dean M.  

BioDrugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 193-195

Adis International

Access to resources Recommend Favorite

Bevacizumab Plus Platinum-Based Chemotherapy: In Advanced Non-Small Cell Lung Cancer

By Wagstaff Antona J.   Keam Susan J.   McCormack Paul L.  

BioDrugs, Vol. 23, Iss. 3, 2009-06 ,pp. : 187-196

Adis International

Access to resources Recommend Favorite